Innovative ETFs Channel Biotech ETFs Strengthen as Amgen Invests in China’s BeiGene By Max ChenNovember 1, 2019
Disruptive Technology Channel How ETF Investors Could Enhance a Portfolio with Disruptive Innovative Companies By Max ChenOctober 1, 2019
Disruptive Technology Channel Focusing on Disruptive Innovation for Changing Markets By Max ChenSeptember 30, 2019
Innovative ETFs Channel Drug Pricing Reforms Keep Pressure on Biotech, Healthcare ETFs By Max ChenSeptember 26, 2019
Beyond Basic Beta Channel 8 ETFs to Capture Opportunities in Healthcare Sector By Max ChenAugust 22, 2019
Innovative ETFs Channel Healthcare Providers ETF Breaks Out After White House Ends Drug Rebate Rule By Max ChenJuly 11, 2019
Innovative ETFs Channel Biotech ETFs Strengthen After Judge Blocks Trump’s Drug Pricing Rule By Max ChenJuly 9, 2019
Beyond Basic Beta Channel ETF of the Week: Robo Global Healthcare Technology and Innovation ETF (HTEC) By Ben HernandezJuly 9, 2019
Alternatives Channel Sector ETFs Most at Risk of Earning Disappointments Ahead By Max ChenJuly 2, 2019
Disruptive Technology Channel 4 ARK ETFs to Help Investors Access Innovative Disruptors By Max ChenJune 21, 2019
Innovative ETFs Channel Biotech ETFs Are Breaking Out on Pfizer’s Array Biopharma Deal By Max ChenJune 17, 2019
Leveraged & Inverse Channel Health Care ETFs Could be Cure for Trade War Blues By Ben HernandezMay 29, 2019
Innovative ETFs Channel Look to Healthcare ETFs for Stability in a Shaky Market By Max ChenMay 10, 2019